小儿房性心动过速药物治疗分析

The Clinical Analysis of Drug Therapy with Children Atrial Tachycardia

目的：探讨小儿房性心动过速药物治疗效果。方法：总结2008年1月至2014年11月我院收治的小儿房性心动过速患儿46例,分析其药物治疗特点、疗效及随访情况。结果：46例房性心动过速患儿,男30例,女16例,年龄1个月~11岁,平均（36.75±3.50）个月。41例患儿进行了6个月~4年随访,平均随访时间（2.85±1.05）年,有5例失访。所有患儿给予抗心律失常药物治疗,均有效转复心律,其中30例给予胺碘酮转复,10例应用普罗帕酮转复,5例应用胺碘酮＋美托洛尔成功转复,1例给予三磷酸腺苷（ATP）转复,治疗成功率100%,无死亡病例。结论：胺碘酮治疗小儿房性心动过速效果明显,特别对于婴幼儿持续性房性心动过速,具有较好疗效,38例患儿随访提示小儿房性心动过速可能为自限性疾病。

Objective： To study drug therapy effects to children atrial tachycardia. Methods： Forty-six children atrial tachycardia cases that were treated with medicines in our hospital from Janary, 2008 to November, 2014 were summarized and the characteristics of drug therapy, efficacy and follow-up outcome were discussed. Results： In all cases, included 30 males and 16 females, the youngest was 1 month, the oldest was 11 years, the average age was （36.75±3.50） months. Forty-one of 46 cases were followed up regularly. The follow-up term was 6 months to 4 years, average term was （2.85±1.05） years. Five cases were missed. All atrial tachyeardia cases were terminated successfully with medicines involve amiodarone for 30 cases, propafenone for 10 cases, amiodarone combined to metoprolol for 5 cases, ATP for 1 ease. The success rate was 100%. No death case. Conclusion： Amiodarone is more effective in treating atrial tachyeardia, especially for infant persistent atrial tachycardia, that means children atrial tachycardia may be a self-healing disease.